
Ashler et Manson (MLAEM) | Stock Overview & Key Data
Ashler et Manson Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €4.58 on December 26, 2022
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Ashler et Manson MLAEM | 10.16M Small-cap | 0.00% | 1.72% | 31.11% | 47.50% | 47.50% | -23.38% | -18.62% | 30.39% |
Firstcaution SA MLFIR | 151.94M Mid-cap | 0.00% | 0.00% | 9.84% | 10.44% | 10.44% | 10.44% | 127.12% | 106.15% |
BNP Paribas S.A BNP | 93.33B Large-cap | -0.38% | 8.17% | 7.59% | 17.30% | 40.73% | 35.75% | 81.85% | 120.52% |
Axa S.A CS | 92.22B Large-cap | -1.87% | 2.60% | 2.45% | 14.80% | 23.74% | 25.45% | 81.78% | 143.65% |
Credit Agricole S.A ACA | 51.73B Large-cap | -0.29% | 6.16% | -2.96% | 9.15% | 27.89% | 24.34% | 87.27% | 91.69% |
Société Générale GLE | 45.05B Large-cap | -1.60% | 16.99% | 17.37% | 52.81% | 113.59% | 169.27% | 167.90% | 308.76% |
Ownership & Short Interest
Ashler et Manson Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Ashler et Manson would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MLAEM's 52-week high and low?
- In the last 52 weeks, Ashler et Manson reached a high of €3.08 (on June 12, 2024) and a low of €1.60 (on October 23, 2024).
- What is the market cap and P/E ratio for MLAEM?
- Curious about Ashler et Manson's size and valuation? Its market capitalization stands at 10.16M. When it comes to valuation, the P/E ratio (trailing twelve months) is 59.00, and the forward P/E (looking ahead) is N/A.
- Does MLAEM pay dividends? If so, what's the yield?
- As for dividends, Ashler et Manson isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ashler et Manson's main competitors or similar companies to consider before investing?
When looking at Ashler et Manson, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Firstcaution SA
MLFIR151.94M Financial Services Insurance Brokers 10.44% 127.12% BNP Paribas S.A
BNP93.33B Financial Services Banks - Regional 35.75% 81.85% Axa S.A
CS92.22B Financial Services Insurance - Diversified 25.45% 81.78% Credit Agricole S.A
ACA51.73B Financial Services Banks - Regional 24.34% 87.27% Société Générale
GLE45.05B Financial Services Banks - Regional 169.27% 167.90% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ashler et Manson? (e.g., ROE, Debt/Equity)
- To get a sense of Ashler et Manson's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.62%, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MLAEM?
- Looking at Ashler et Manson's growth, its revenue over the trailing twelve months (TTM) was €406K. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of MLAEM stock is held by insiders and institutions?
- Wondering who owns Ashler et Manson stock? Company insiders (like executives and directors) hold about 61.36% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.